Literature DB >> 8361341

Soluble derivatives of beta/A4 amyloid protein precursor in human cerebrospinal fluid are both N- and O-glycosylated.

F Saito1, K Yanagisawa, T Miyatake.   

Abstract

The linkage of the glycan chain to the beta/A4 amyloid protein precursor (APP) in cerebrospinal fluid (CSF) was studied by Western blot analysis. The apparent molecular weight of APP in CSF was reduced from 103 to 100 kDa by N-glycanase, and to 96 kDa by O-glycanase treatment, respectively. These data indicate that APP is both N- and O-glycosylated in one molecule. The extent of glycosylation of APP was not altered in the CSF from patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361341     DOI: 10.1016/0169-328x(93)90164-k

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  4 in total

Review 1.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

2.  The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.

Authors:  Jia-Wei Min; Yanying Liu; David Wang; Fangfang Qiao; Hongmin Wang
Journal:  J Neurochem       Date:  2017-12-19       Impact factor: 5.372

3.  LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.

Authors:  Jianhui Wang; Xiaorui Cheng; Ju Zeng; Jiangbei Yuan; Zhongfu Wang; Wenxia Zhou; Yongxiang Zhang
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

Review 4.  The Glycobiology of Pulmonary Arterial Hypertension.

Authors:  Shia Vang; Phillip Cochran; Julio Sebastian Domingo; Stefanie Krick; Jarrod Wesley Barnes
Journal:  Metabolites       Date:  2022-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.